Arkolith/Insider Trading/DRMA/Form 4

Proehl Gerald T

President, CEO and Chairman, Director, 10% OwnerDermata Therapeutics, Inc. (DRMA) · full profile →Form 4 · filed Aug 17, 2021
Net Buying
Open-Market Buys
$50K
Open-Market Sells
$0
Net Open-Market Flow
$50K
Transactions
21
10 non-derivative · 11 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 17, 2021Conversion(C)9K——9K
Aug 17, 2021Conversion(C)36K——36K
Aug 17, 2021Buy(P)143K——153K
Aug 17, 2021Conversion(C)112K——1.4M
Aug 17, 2021Conversion(C)182K——1.6M
Aug 17, 2021Conversion(C)1.2M——2.8M
Aug 17, 2021Conversion(C)86K——2.9M
Aug 17, 2021Conversion(C)361K——1.3M
Aug 17, 2021Conversion(C)18K——18K
Aug 16, 2021Buy(P)10K$4.96$50K10K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 17, 2021Conversion(C)3.7M—$00
Aug 17, 2021Conversion(C)60K—$00
Aug 17, 2021Conversion(C)1.8M—$00
Aug 17, 2021Conversion(C)574K—$00
Aug 17, 2021Conversion(C)28K—$028K
Aug 17, 2021Buy(P)143K——143K
Aug 17, 2021Conversion(C)120K—$00
Aug 17, 2021Conversion(C)25.6M—$00
Aug 17, 2021Conversion(C)241K—$00
Aug 17, 2021Conversion(C)2.4M—$00
Aug 17, 2021Conversion(C)2.3M—$00

Transaction Codes

C
Conversion of a derivative
P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000905718-21-001094) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Dermata Therapeutics, Inc.

Build

Ask your agent about DRMA insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0000905718-21-001094"
Ask your agent
Use Arkolith to summarize insider buying and selling at Dermata Therapeutics, Inc.
over the last 90 days and cite the filings.